当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
FIBRYNA; FIBRYGA, Fibrinogen (Human)
申请企业
Octapharma Pharmazeutika Produktionsges.m.b.H.
药品名称
FIBRYNA; FIBRYGA, Fibrinogen (Human)
承诺描述
A prospective observational study in children and adults with congenital afibrinogenemia and hypofibrinogenemia treated with FIBRYGA for at least 10 major bleeding events to further characterize the risk of thromboembolic events following FIBRYGA treatment.